Innoviva (INVA) FCF Margin Growth (5y) (2016 - 2026)
Innoviva (INVA) FCF Margin Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Innoviva | 1.54 Bn | 968.79 Mn | 90.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -304,726.00 |
| Mar 31, 2026 | -532,163.00 |
| Sep 30, 2025 | -3,644.00 |
| Jun 30, 2025 | -5,713.00 |
| Mar 31, 2025 | -3,853.00 |
| Sep 30, 2024 | -3,890.00 |
| Jun 30, 2024 | -4,437.00 |
| Mar 31, 2024 | 134,653.00 |
| Sep 30, 2023 | -4,958.00 |
| Jun 30, 2023 | 127,352.00 |
| Mar 31, 2023 | 129,350.00 |
| Sep 30, 2022 | -1,680.00 |
| Jun 30, 2022 | 188,495.00 |
| Mar 31, 2022 | 434,011.00 |
| Sep 30, 2021 | 3,352.00 |
| Jun 30, 2021 | 305,201.00 |
| Mar 31, 2021 | 532,715.00 |
| Dec 31, 2020 | 1.69 Mn |
| Sep 30, 2020 | 6,448.00 |
| Jun 30, 2020 | 8,067.00 |